Gastroenterology & Endoscopy Practice Database

The gastroenterology market stands out for its predictable, recurring procedure volumes driven by mandated colorectal cancer screening guidelines. Every American over 45 is recommended for colonoscopy screening, creating sustained demand that makes GI practices reliable, long-term customers for equipment, supplies, and services.

Market Overview

The US gastroenterology market generates approximately $30 billion annually and continues to grow driven by aging demographics, expanded screening guidelines, and increasing prevalence of digestive diseases. The total addressable market for vendors selling to GI practices includes:

• Endoscopy equipment and accessories: $4.5 billion annually
• GI pharmaceuticals: $12 billion (IBD biologics, GERD medications, hepatitis treatments)
• Practice management and EHR systems: $800 million
• Pathology and laboratory services: $2 billion
• Anesthesia services for endoscopy centers: $1.5 billion

The specialty is experiencing consolidation, with private equity-backed platforms acquiring independent practices and building regional networks of ambulatory surgery centers (ASCs).

Practice Landscape

• Practice Types:
• **Large single-specialty groups (40%)** - 5-50+ physicians, often owning multiple ASCs, high procedure volumes, centralized purchasing
• **Hospital-employed practices (30%)** - Integrated into health systems, decisions influenced by hospital procurement
• **Small groups and solo practitioners (25%)** - 1-4 physicians, may use hospital or independent ASC facilities
• **Academic medical centers (5%)** - Teaching institutions with research focus, early adopters of new technology

• Ownership Models:
• Physician-owned practices remain common but declining as PE consolidation accelerates
• Over 5,000 ambulatory endoscopy centers, majority physician-owned
• Growing presence of management services organizations (MSOs) providing back-office support

• Geographic Distribution:
• Highest concentration in suburban areas with aging populations
• Florida, California, Texas, and the Northeast have the most practices
• Underserved rural areas present growth opportunities for mobile endoscopy services

Key Decision Makers

• Physician Leadership:
• Managing partners and medical directors control clinical purchasing
• Individual physicians influence equipment preferences and pharmaceutical choices
• Advanced endoscopists (ERCP/EUS specialists) drive high-value equipment decisions

• Administrative Leadership:
• Practice administrators manage vendor relationships and contracts
• ASC directors oversee facility operations and supply chain
• CFOs and financial managers evaluate capital equipment purchases

• Purchasing Influencers:
• Endoscopy nurses and techs influence disposable and accessory selection
• GI hospitalists in larger systems affect inpatient-related purchasing
• Quality directors evaluate outcomes data for equipment decisions

What's In Our Database

Our gastroenterology practice database includes comprehensive information for targeted sales and marketing outreach:

• Practice Information:
• Practice name, address, phone, fax
• Website and email contacts
• Number of physicians and locations
• ASC ownership and affiliations
• Health system relationships

• Provider Details:
• Physician names and credentials
• NPI numbers for claims verification
• Subspecialty focus (hepatology, IBD, advanced endoscopy)
• Medical school and fellowship training
• Years in practice

• Operational Data:
• Estimated procedure volumes
• EHR and practice management systems in use
• Payer mix indicators
• Accreditation status

Use Cases

• Medical Device Sales:
• Target high-volume ASCs for endoscope and accessory sales
• Identify practices upgrading equipment based on age of current systems
• Segment by procedure type (colonoscopy-focused vs. advanced therapeutic endoscopy)

• Pharmaceutical Marketing:
• Reach gastroenterologists prescribing IBD biologics, GERD medications, or hepatitis treatments
• Identify hepatology-focused practices for liver disease drug launches
• Target by patient volume for sampling programs

• Healthcare IT:
• Market EHR and practice management systems to independent practices
• Target ASCs for procedure documentation and quality reporting solutions
• Reach practices seeking patient engagement and scheduling tools

• Business Services:
• Revenue cycle management for practices with ASC billing complexity
• Recruiting firms targeting GI physician shortages
• Medical billing and coding services for endoscopy centers

• Market Research:
• Analyze market penetration and competitive landscape
• Survey gastroenterologists for product development insights
• Track consolidation trends and PE activity

Industry Statistics

Market Size - $30 billion annually in the US Number of Practices - ~12,000 gastroenterology practices Active Physicians - ~16,500 gastroenterologists Colonoscopies - 19 million performed annually Upper Endoscopies - 7 million annually Ambulatory Centers - 5,000+ endoscopy ASCs Average Colonoscopy Reimbursement - $3,000-$5,000 ERCP Volume - 500,000+ procedures annually IBD Prevalence - 3 million Americans affected Hepatitis C Market - $4+ billion in direct-acting antivirals

Why Target Gastroenterology Practices

High Procedure Volume - GI practices perform more outpatient procedures than nearly any other specialty, creating consistent demand for supplies, equipment, and services.

Recurring Revenue Potential - Screening colonoscopy guidelines ensure predictable patient flow, making GI practices stable, long-term customers.

Technology Adoption - GI practices readily adopt new endoscopic technologies, AI-assisted polyp detection, and advanced imaging systems.

ASC Ownership - Physician-owned ASCs control their own purchasing decisions, often more accessible than hospital procurement committees.

Consolidation Opportunities - PE-backed platforms actively acquiring practices create opportunities for enterprise sales and vendor consolidation.

Pharmaceutical Spend - High-cost biologics for IBD and specialty medications for liver disease make GI a priority market for pharma.

Disposable Consumption - Single-use accessories, biopsy forceps, and polypectomy snares drive ongoing supply sales.

Frequently Asked Questions